2-(1-(3,5-difluorophenyl)-5-(2-hydroxyphenyl)-1H-1,2,4-triazol-3-yl)-5-(trifluoromethyl)phenol

ID: ALA5189198

PubChem CID: 168278403

Max Phase: Preclinical

Molecular Formula: C21H12F5N3O2

Molecular Weight: 433.34

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Oc1cc(C(F)(F)F)ccc1-c1nc(-c2ccccc2O)n(-c2cc(F)cc(F)c2)n1

Standard InChI:  InChI=1S/C21H12F5N3O2/c22-12-8-13(23)10-14(9-12)29-20(16-3-1-2-4-17(16)30)27-19(28-29)15-6-5-11(7-18(15)31)21(24,25)26/h1-10,30-31H

Standard InChI Key:  ZXTRTMRQAGDMFM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0844   -1.2378    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5829   -0.7529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3280    0.0317    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4970    0.0317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7519   -0.7529    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9096    0.7464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4972    1.4611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9091    2.1732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7346    2.1732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1464    1.4629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7383    0.7464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1471    2.8879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9723    2.8879    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1471    3.7146    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.4325    3.3004    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3280    1.4611    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3800   -0.9665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5938   -1.7635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3887   -1.9757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9723   -1.3920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7613   -0.5985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9660   -0.3805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7524    0.4165    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0844   -2.0630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7990   -2.4758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7982   -3.2984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0834   -3.7112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6283   -3.3020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6332   -2.4773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3430   -3.7146    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.5128   -3.7111    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  6  4  1  0
  7  6  2  0
  8  7  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
  6 11  1  0
  9 12  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
  7 16  1  0
 17  2  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 17 22  1  0
 22 23  1  0
 24  1  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 28 27  1  0
 29 28  2  0
 24 29  1  0
 28 30  1  0
 26 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5189198

    ---

Associated Targets(Human)

HaCaT (4069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PC-12 (7051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 433.34Molecular Weight (Monoisotopic): 433.0850AlogP: 5.31#Rotatable Bonds: 3
Polar Surface Area: 71.17Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.61CX Basic pKa: CX LogP: 6.34CX LogD: 6.13
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.43Np Likeness Score: -1.13

References

1. Lao Y, Wang Y, Chen J, Huang P, Su R, Shi J, Jiang C, Zhang J..  (2022)  Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury.,  236  [PMID:35390713] [10.1016/j.ejmech.2022.114315]

Source